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Abstract
Background: Population stratification is a key concern for genetic association analyses. In addition, extreme
homogeneity of ethnic origins of a population can make it difficult to interpret how genetic associations in that
population may translate into other populations. Here we have evaluated the genetic substructure of samples from
the Cache County study relative to the HapMap Reference populations and data from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI).
Results: Our findings show that the Cache County study is similar in ethnic diversity to the self-reported “Whites”
in the ADNI sample and less homogenous than the HapMap CEU population.
Conclusions: We conclude that the Cache County study is genetically representative of the general European
American population in the USA and is an appropriate population for conducting broadly applicable genetic
studies.
Background
Cryptic population differences due to heterogeneity have
confounding effects on association studies, especially
when analyzing complex traits and gene-gene interac-
tions. It is also possible that genetic associations that are
observed in very homogeneous populations may not be
generalizable to other populations.
The Cache County study is a large longitudinal cohort
study of memory, health, and aging that was initiated in
1994. This sample of 5,092 individuals represents approxi-
mately 90% of the Cache County population aged 65 and
older at that time. These data are a valuable resource in
genetic studies of Alzheimer’s disease (AD), as well as
otherdiscussion forms of dementia [1]. The founding
populations and migrations to Utah by early members of
the Church of Jesus Christ of Latter Day Saints have been
studied extensively[2-4]. These studies have concluded
that due to the large founding population, high rates of
gene flow and diversity of source populations the Utah
population has allele frequencies that are quite similar to
the general European American population in the United
States. As it was collected from one county in Utah, there
have been questions as to how the genetic diversity in the
Cache County sample compares to that of more broadly
collected European American samples and whether that
diversity affects the validity or generalizability of results
obtained from the Cache County study.
The Cache County study is a large longitudinal cohort
study of memory, health, and aging that was initiated in
1994. This sample of 5,092 individuals represents approxi-
mately 90% of the Cache County population aged 65 and
older at that time. These data are a valuable resource in
genetic studies of Alzheimer’s disease (AD), as well as
other forms of dementia [1]. The founding populations
and migrations to Utah by early members of the Church
of Jesus Christ of Latter Day Saints have been studied
extensively[2-4]. These studies have concluded that due to
the large founding population, high rates of gene flow and
diversity of source populations the Utah population has
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allele frequencies that are quite similar to the general Eur-
opean American population in the United States. As it was
collected from one county in Utah, there have been ques-
tions as to how the genetic diversity in the Cache County
sample compares to that of more broadly collected Eur-
opean American samples and whether that diversity affects
the validity or generalizability of results obtained from the
Cache County study.
The purpose of this study is to compare the genetic
structure of the Cache County study, which was col-
lected from one county in northern Utah, to that of the
Alzheimer’s Disease Neuroimaging Initiative, a sample
that was collected from several sites around the USA,
and data from several other populations from the Inter-
national HapMap Project.
Methods
Sample collection and genotyping
The Cache County study originally included 5,092 per-
manent residents of Cache County over the age of 64.
Details of collection methods and demographics of the
Cache County samples have been reported previously
[1]. Briefly, samples underwent four triennial waves of
data collection in a multi-stage dementia screening and
assessment protocol. DNA was obtained from blood and
buccal swabs as described by Breitner et al. [1] All study
procedures were approved by the Institutional Review
Boards of Utah State, Duke and Johns Hopkins univer-
sitys. DNA from 506 Cache County study participants
was genotyped using the Illumina OmniExpress chip;
DNA from 234 others was genotyped using the Illumina
2.5M chip.
The broader population data with which we will com-
pare the Cache data was collected by The International
HapMap Project [5] and the Alzheimer’s Disease Neuroi-
maging Initiative (ADNI) [6]. The International Hapmap
Project (phase 3, draft release 2) consists of SNP genotyp-
ing data from the populations in Table 1 [5]. The data
were collected using two genotyping platforms: Illumina
Human1M by the Wellcome Trust Sanger Institute and
Affymetrix SNP 6.0 by the Broad Institute. They are avail-
able for download from http://hapmap.ncbi.nlm.nih.gov/
downloads/genotypes/2009-01_phaseIII/plink_format.
The ADNI samples are part of a longitudinal study
designed to measure the progression of mild cognitive
impairment (MCI) and early AD [6]. The primary goal of
ADNI has been to test whether serial magnetic resonance
imaging (MRI), PET, other biological markers, and clinical
and neuropsychological assessment can be combined to
measure the progression of MCI and early AD (PI:
Michael W. Weiner, M.D., VA Medical Center and Uni-
versity of California - San Francisco). ADNI is the result of
efforts of many co- investigators from a broad range of
academic institutions and private corporations, and sub-
jects have been recruited from over 50 sites across the U.
S. and Canada. For up-to-date information, see http://
www.adni-info.org. Data for the present analysis were
downloaded from the ADNI web site in March 2013. We
used self-reported race to label three ethnic groups within
the ADNI samples, Black/African-American (ADNI1),
White (ADNI2), or Asian (ADNI3).
Data preparation and quality control
For the distance-based clustering, the following data
preparation steps were taken. First, all palindromic mar-
kers (alleles A/T or G/C) were excluded to correct for
strand differences between datasets (120,541 markers
excluded). We then excluded all markers that were not
genotyped in at least two of the three data sets (342,603
markers included). Finally, we removed all markers with
genotyping rates lower than 95% across all individuals
(263,883 markers included). Individuals with genotyping
rates of lower than 95% for the included markers were
excluded from the analysis. The final set consisted of
2,274 individuals, 400 from Cache, 626 from ADNI, and
1,248 from the various HapMap populations.
For the model-based clustering, we compared Cache
to only two populations (CEU and ADNI2), because
Table 1 HapMap populations with Abbreviations
Population Abbreviation
African ancestry in Southwest USA ASW
CEPH (Utah residents with ancestry from northern and western Europe) CEU
Han Chinese in Beijing, China CHB
Chinese in Metropolitan Denver, Colorado CHD
Gujarati Indians in Houston, Texas GIH
Japanese in Tokyo, Japan JPT
Luhya in Webuye, Kenya LWK
Mexican ancestry in Los Angeles, California MEX
Maasai in Kinyawa, Kenya MKK
Tuscan in Italy TSI
Yoruban in Ibadan, Nigeria YRI
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they appeared most similar in the distance-based method.
This included a total of 1,155 samples. Pruning of markers
to minimize redundant information due to linkage dise-
quilibrium was done using the following parameters in
PLINK: r2 > .10 in 50 SNP windows, incremented by 5
SNPs across the genome (61616 markers included).
Methods for distance and model-based clustering analysis
The distance-based method of comparison is a standard
classical (metric) multi-dimensional scalar analysis of
pairwise identity by state distances. Distances were cal-
culated and scaling was performed using the PLINK
whole genome association analysis toolset [7].
In addition to distance scaling, Bayesian modeling tech-
niques were leveraged to identify clustering of samples
from Cache and the other European-American popula-
tions. The model-based clustering method was provided
using the program Structure [8]. Burn-in duration was
set at 5,000 repetitions with a run duration of 10,000
repetitions per software recommendations[8]. We used
an admixture type ancestry model due to the generally
admixed nature of the European American population
and specified for a model of correlated allele frequency
across result populations. The statistic of interest gener-
ated by Structure is a probability, Pr (Z | P, X), where Z
is a vector containing the assignment to a cluster of each
individual, P specifies the frequency of each allele at each
locus (a statistic that is calculated by Structure to charac-
terize each cluster), and × is the given genotypes of the
sampled individuals.
Results
Results from the distance-based clustering approach
Results indicate that samples from the Cache County
study cluster very closely with other European American
samples (ADNI2 and CEU; Figure 1). In addition, the
Cache County samples exhibit a range of diversity that
is similar to that of self reported whites from the ADNI
sample (ADNI2; Figure 2).
Results from the model-based clustering approach
Structure results indicate that the observed range of gen-
otypes is most likely to have occurred if the individuals
came from two separate populations, as opposed to any
other number of populations from one to five (table 2).
Additionally, the majority of individuals came from only
one of the two proposed clusters (table 3).
Discussion
The Cache County study has provided important infor-
mation about genetic factors that influence aging and
Alzheimer’s disease [1,9-13]. The results reported here
indicate that despite being collected from a single county
in northern Utah, these samples are comparable in levels
of diversity to those of self-reported European-Americans
collected at multiple sites across the United States. In
addition, we observed no evidence of problematic popu-
lation stratification between the Alzheimer’s disease cases
and non-demented controls in the Cache samples. This
indicates that association studies in this population are
unlikely to produce type-I error due to population
stratification.
The distance-based clustering method identified simi-
larity between the majority of European-American indi-
viduals, including those from Cache County, CEU, and
ADNI2. The model-base clustering method found the
optimum solution to be two clusters, one small cluster
with a small number of outliers from each of the three
samples (Cache, ADNI2, and CEU) and a larger cluster
that included the vast majority of samples.
Figure 1 All individuals with scaling components. ADNI1 refers to individuals participating in the ADNI study who self-identified as “Black/
African-American”, ADNI2 refers to those who self-identified as “White”, and ADNI 3 refers to those who self-identified as “Asian”. All other
abbreviations are from Table 1. In Cache samples, case or control status refers to clinical diagnosis of Alzheimer’s disease. Dashed box designates
the region displayed in figure 2 and includes the ADNI2, CEU, Cache Cases and Controls.
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These data suggest that the population substructure in
the Cache County study is comparable to that of other
European-American samples that are more broadly col-
lected, (i.e. the ADNI samples). In addition, these findings
are consistent with the results reported previously on the
larger population of the early population of the state of
Utah [2-4]. We conclude that despite concerns about the
limited geographic range of sample collection in the Cache
County study, the results of genetic studies in this popula-
tion, such as gene discovery, validation, and estimates of
population level effects, are as broadly applicable to other
populations of European American ancestry as that of the
Alzheimer’s Disease Neuroimaging Initiative.
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